No profile data available.
Envista Holdings Corporation (NVST) is a healthcare company in the additional specific healthcare equipment industry, based in Brea, United States, with about 12,000 full-time employees.
It reported revenue of $2.72 billion for fiscal year 2025, up 8.3% from fiscal year 2024, and net income of $47.00 million. In Q2 2026 (the quarter ended June 30, 2026) revenue was $730.50 million, up 7.1% from a year before. Its largest business segment, Specialty Products & Technologies, brought in 64% of segment revenue in fiscal year 2025; United States was the largest region with 47%. Its market capitalization was $3.69 billion as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables.
Envista Holdings reported $2.72 billion in revenue for fiscal year 2025, up 8.3% from $2.51 billion in fiscal year 2024. In Q2 2026 revenue was $730.50 million.
Specialty Products & Technologies, with $1.75 billion or 64% of segment revenue in fiscal year 2025. Next: Equipment & Consumables (36%).
United States: 47% of revenue by region in fiscal year 2025, followed by All Other (46%).
$3.69 billion as of October 9, 2026.
Listed companies of a similar size in the same industry (additional specific healthcare equipment) include Align Technology, Inc. (ALGN), Haemonetics Corporation (HAE), Telix Pharmaceuticals Limited (TLX), Establishment Labs Holdings Inc. (ESTA).